AAA December 2012 – Page 2

Sanofi-Genzyme, Shire back Ultragenyx’s $75m round

Sanofi-Genzyme BioVentures1, a corporate venturing unit of France-based healthcare company Sanofi Aventis, and Ireland-based pharmaceutical company Shire are joined by a large crowd of investors in the series B for the rare genetic disorder treatment company.

Northgate helps TubeMogul stream $20m

Northgate Capital, which is majority owned by India-based financial services group Religare Enterprises, backs video marketing company TubeMogul, after deals backing US-based social data company DataSift in November and US-based IT infrastructure company Scale Computing in October.

Applied Ventures backs Aventa

Christopher Moran, general manager of Applied Ventures, says: “We are excited about Aventa’s progress in developing critical manufacturing technology for this emerging alternative energy sector. HTS technology has tremendous potential, and we are pleased that this investment will be used to make advanced grid solutions more affordable.”

Sightly catches Bright’s eye

Bright Capital Digital, which is part of Bright Capital, the corporate venturing unit of Russia-based conglomerate Ru-Com, has led a $5.6m round raised by Sightly, a US-based video platform. Bright Capital Digital was joined backing Temecula, California-based Sightly, which helps businesses market with videos, by venture firms Foresight Ventures, Floodgate, Tomorrow Ventures, Bullpen Capital, Mack… Continue reading Sightly catches Bright’s eye